Health
-
Trump closes first round of drug price negotiations with Regeneron deal
President Trump announced a significant drug pricing agreement with Regeneron on Thursday, marking the final deal of the 17 agreements…
Read More » -
Peptides Are Everywhere—But Who’s Actually Qualified To Give Advice?
Peptides have taken the health and wellness world by storm, with claims of benefits ranging from skin health and weight…
Read More » -
RFK Jr.’s rhetoric shifts on key MAHA issues
The latest edition of D.C. Diagnosis, STAT’s newsletter focusing on the politics and policy of health and medicine, delves into…
Read More » -
Progress For Preeclampsia
Preeclampsia is a serious condition that affects many pregnant women, with potentially life-threatening consequences for both mother and baby. Recent…
Read More » -
Kennedy talking a new, more moderate version of MAHA agenda
Health secretary Robert F. Kennedy Jr. has recently made a significant pivot in his stance on vaccines, moving from a…
Read More » -
Using AI To Personalize Healthcare–Without Losing Patient Trust
In this week’s edition of InnovationRx, the focus is on the potential and challenges of utilizing AI to personalize healthcare…
Read More » -
JAMA study: 988 hotline linked to 11% drop in youth suicide deaths
The introduction of the 988 national suicide and crisis hotline in the U.S. has had a significant impact on reducing…
Read More » -
The UK Just Passed A Generational Smoking Ban. Could America Be Next?
The UK Parliament recently made history by passing the Tobacco and Vapes Bill, which will ban the sale of tobacco…
Read More » -
AACR in 30 Seconds: Revolution Medicines data, NCI director, wildfires
The American Association of Cancer Researchers’ annual meeting is always a hotbed of groundbreaking research and this year is no…
Read More » -
There’s No Such Thing As Brain Honey
False reports claiming that a product based on honey can cure Alzheimer’s disease have been circulating on social media, including…
Read More »